Use of low toxicity adjuvants and killed virus to induce protective immunity against the Friend murine leukaemia retrovirus-induced disease

Vaccine

Volumn 10, Issue 5, 1992, Pages 353-356

  Ishihara, Chiaki ^a   Miyazawa, Masaaki ^a   Nishio, Jane ^a   Azuma, Ichiro ^b   Chesebro, Bruce ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adjuvants; Friend murine leukaemia; low toxicity; retrovirus

Indexed keywords

ADJUVANT; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG TOXICITY; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; RETROVIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; FRIEND MURINE LEUKEMIA VIRUS; IMMUNIZATION; LEUKEMIA, EXPERIMENTAL; MICE; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0026551509     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(92)90378-W     Document Type: Article

References (32)

1. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia
2. Immunosuppression by leukemia viruses
3. Immunodepression by oncogenic viruses
4. Influence of the murine major histocompatibility complex (H-2) on Friend leukemia virus-induced immunosuppression
5. The molecular biology of Friend virus
6. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection
7. Induction of protective immunity against an immunosuppressive mouse retrovirus: possible parallels with HIV
8. Different H-2 subregions influence immunization against retrovirus and immunosuppression
9. Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera
10. Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70
11. Immunoprevention of Friend virus induced erythroleukemia by vaccination with viral envelope glycoprotein complexes
12. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant
13. Immunomodifiers in vaccines
14. Immunoadjuvants for vaccine
15. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: Dose-response and local reactions observed with selected compounds
16. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: Adaptability to various vehicles and pyrogenicity
17. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A
18. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18)
19. Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeS mice
20. Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide
21. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome
22. Pathogenesis of arteritis of SL/Ni mice: possible lytic effect of anti-gp70 antibodies on vascular smooth muscle cells
23. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host-range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses
24. Host genetic control of recovery from Friend leukemia virus induced splenomegaly: mapping of a gene within the major histocompatibility complex
25. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen: identification of class II loci of the H-2 as immune response genes
26. Nonspecific and antigen-specific stimulation of host defense mechanisms by lipophilic derivatives of muramyl dipeptides
27. General pharmacological properties of Muroctasin
28. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595
29. Purification and structural determination of nontoxic lipid A from the rough mutant of Salmonella typhimurium
30. Modulation of humoral and cell-mediated immune responses by a structurally established nontoxic lipid A
31. Partial protection of susceptible mice against Friend retrovirus-induced leukemia with vaccinia-Friend gag recombinant vaccines
32. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein